JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB179524

Anti-PKC eta antibody [EPR18513]

5

(1 Review)

|

(11 Publications)

Rabbit Recombinant Monoclonal KPCL antibody. Suitable for IP, WB and reacts with Mouse, Rat, Human samples. Cited in 11 publications.

View Alternative Names

PKCL, PRKCL, PRKCH, Protein kinase C eta type, PKC-L, nPKC-eta

8 Images
Immunoprecipitation - Anti-PKC eta antibody [EPR18513] (AB179524)
  • IP

Supplier Data

Immunoprecipitation - Anti-PKC eta antibody [EPR18513] (AB179524)

PKC eta was immunoprecipitated from 1mg of Mouse lung whole cell lysate with ab179524 at 1/50 dilution. Western blot was performed from the immunoprecipitate using ab179524 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.

Lane 1 : Mouse lung whole cell lysate 10ug (Input).

Lane 2 : ab179524 IP in Mouse lung whole cell lysate.

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab179524 in Mouse lung whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 30 seconds.

All lanes:

Immunoprecipitation - Anti-PKC eta antibody [EPR18513] (ab179524)

Predicted band size: 78 kDa

Observed band size: 40 kDa,78 kDa

false

Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)
  • WB

Supplier Data

Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)

Blocking/Dilution buffer : 5% NFDM/TBST.

The antibody recognizes the full length (~78KD) and the catalytic domain (~40KD) of PKC eta.
(Geraldes P and King GL, 2010. Circ Res. 106, 1319-1331; Newton AC. 1995. J. Biol. Chem. 270, 28495-28498)

All lanes:

Western blot - Anti-PKC eta antibody [EPR18513] (ab179524) at 1/10000 dilution

Lane 1:

MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 10 µg

Lane 2:

PC-3 (Human prostate adenocarcinoma cell line) whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution

Predicted band size: 78 kDa

Observed band size: 45 kDa,78 kDa

false

Exposure time: 1min

Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)
  • WB

Supplier Data

Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)

Blocking/Dilution buffer : 5% NFDM/TBST.

The antibody recognizes the full length (~78KD) and the catalytic domain (~40KD) of PKC eta.
(Geraldes P and King GL, 2010. Circ Res. 106, 1319-1331; Newton AC, 1995. J. Biol. Chem. 270, 28495-28498)

All lanes:

Western blot - Anti-PKC eta antibody [EPR18513] (ab179524) at 1/2000 dilution

Lane 1:

Human fetal brain lysate at 10 µg

Lane 2:

Human fetal heart lysate at 10 µg

Lane 3:

Human fetal kidney lysate at 10 µg

Secondary

All lanes:

Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/50000 dilution

Predicted band size: 78 kDa

Observed band size: 45 kDa,78 kDa

false

Exposure time: 3min

Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)
  • WB

Supplier Data

Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)

Blocking/Dilution buffer : 5% NFDM/TBST.

The antibody recognizes the full length (~78KD) and the catalytic domain (~40KD) of PKC eta.
(Geraldes P and King GL, 2010. Circ Res. 106, 1319-1331; Newton AC, 1995. J. Biol. Chem. 270, 28495-28498)

All lanes:

Western blot - Anti-PKC eta antibody [EPR18513] (ab179524) at 1/10000 dilution

Lane 1:

Human fetal skin lysate at 10 µg

Lane 2:

Mouse lung lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution

Predicted band size: 78 kDa

Observed band size: 45 kDa,78 kDa

false

Exposure time: 30s

Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)
  • WB

Supplier Data

Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)

Blocking/Dilution buffer : 5% NFDM/TBST.

Active human PKC alpha full length protein (ab55672) contains aa1-672 with GST-tag; Active human PKC beta 1 full length protein (ab60840) contains aa1-671 with GST-tag; Active human PKC beta 2 full length protein (ab60841) contains aa1-673 with GST-tag; Active human PKC gamma full length protein(ab60842) contains aa1-677 with GST-tag; Active human PKC delta full length protein (ab60844) contains aa1-676 with GST-tag; Active human PKC eta full length protein (ab60849) contains aa1-683 with GST-tag; Active human PKC epsilon full length protein (ab60847) contains aa1-737 with GST-tag; Active human PKC theta full length protein (ab56641) contains aa1-706 with GST-tag; Active human PKC mu full length protein (ab60873) contains aa1-912 with GST-tag.

All lanes:

Western blot - Anti-PKC eta antibody [EPR18513] (ab179524) at 1/2000 dilution

Lane 1:

Active human PKC alpha full length protein at 0.02 µg

Lane 2:

Active human PKC beta 1 full length protein at 0.02 µg

Lane 3:

Active human PKC beta 2 full length protein at 0.02 µg

Lane 4:

Active human PKC gamma full length protein at 0.02 µg

Lane 5:

Active human PKC delta full length protein at 0.02 µg

Lane 6:

Active human PKC eta full length protein at 0.02 µg

Lane 7:

Active human PKC epsilon full length protein at 0.02 µg

Lane 8:

Active human PKC theta full length protein at 0.02 µg

Lane 9:

Active human PKC mu full length protein at 0.02 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution

Predicted band size: 78 kDa

false

Exposure time: 1s

Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)
  • WB

Lab

Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)

Western blot : Rabbit Monoclonal [EPR18513] to PKC ab179524 staining at 1/2000 dilution, shown in green; Mouse anti GAPDH ab8245 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 76, 85 kDa in Wild-type A549 cell lysates with no signal observed at this size in PRKCH knockout A549 cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.

All lanes:

Western blot - Anti-PKC eta antibody [EPR18513] (ab179524) at 1/2000 dilution

Lane 1:

Wild-type A549 whole cell lysate at 20 µg

Lane 2:

PRKCH knockout A549 whole cell lysate at 20 µg

Lane 3:

U-2 OS whole cell lysate at 20 µg

Lane 4:

HL-60 whole cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution

Predicted band size: 78 kDa

Observed band size: 76 kDa,85 kDa

false

Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)
  • WB

Supplier Data

Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)

Blocking/Dilution buffer : 5% NFDM/TBST.

The antibody recognizes the full length (~78KD) and the catalytic domain (~40KD) of PKC eta.
(Geraldes P and King GL, 2010. Circ Res. 106, 1319-1331; Newton AC, 1995. J. Biol. Chem. 270, 28495-28498)

All lanes:

Western blot - Anti-PKC eta antibody [EPR18513] (ab179524) at 1/2000 dilution

Lane 1:

Rat skin lysate at 10 µg

Lane 2:

Mouse skin lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution

Predicted band size: 78 kDa

Observed band size: 45 kDa,78 kDa

false

Exposure time: 15s

Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)
  • WB

Supplier Data

Western blot - Anti-PKC eta antibody [EPR18513] (AB179524)

Blocking/Dilution buffer : 5% NFDM/TBST.

The antibody recognizes the full length (~78KD) and the catalytic domain (~40KD) of PKC eta.
(Geraldes P and King GL, 2010. Circ Res. 106, 1319-1331; Newton AC, 1995. J. Biol. Chem. 270, 28495-28498)

All lanes:

Western blot - Anti-PKC eta antibody [EPR18513] (ab179524) at 1/10000 dilution

Lane 1:

Mouse brain lysate at 10 µg

Lane 2:

Rat brain lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution

Predicted band size: 78 kDa

Observed band size: 45 kDa,78 kDa

false

Exposure time: 30s

  • Carrier free

    Anti-PKC eta antibody [EPR18513] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR18513

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

IP, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/50", "IP-species-notes": "<p></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Rat": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Protein kinase C eta (PKC eta) is an enzyme also known as PKC η which belongs to the PKC family of serine/threonine kinases. This protein has a molecular mass of approximately 80 kDa and shows expression in numerous tissues with strong presence in epithelia and the immune system. PKC eta's mechanical function involves phosphorylation of serine and threonine residues on cellular target proteins modulating their activity. It plays a significant role in signal transduction pathways that govern various cellular processes.
Biological function summary

PKC eta involves itself in cellular differentiation and proliferation. It is a component of signal transduction complexes that mediate these processes. In epithelial cells PKC eta modulates cell adhesion and integrity. It also affects immune responses through its action in T-cells and other immune components impacting both innate and adaptive immunity. The enzyme interacts closely with other PKC isoforms allowing it to regulate diverse biological functions through complex networks.

Pathways

PKC eta plays an integral role in growth factor and cytokine signaling pathways. MAPK/ERK and PI3K/AKT pathways include PKC eta as key components for cell survival and proliferation. These pathways facilitate interactions and regulation involving proteins like RAF-1 and AKT coordinating cell growth and apoptosis. PKC eta's positioning in these pathways denotes its significance in maintaining cellular homeostasis and responding to external stimuli.

PKC eta implicates itself in autoimmune conditions like rheumatoid arthritis and in certain types of cancer such as breast cancer. PKC eta influences inflammatory responses often exacerbating autoimmune phenomena by interacting with cytokines and immune receptors. In cancer it may contribute to tumorigenesis by promoting cell survival through PI3K/AKT pathway engagement. It connects with proteins like NF-kB driving pathological changes in cell behavior and immune modulation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in the regulation of cell differentiation in keratinocytes and pre-B cell receptor, mediates regulation of epithelial tight junction integrity and foam cell formation, and is required for glioblastoma proliferation and apoptosis prevention in MCF-7 cells. In keratinocytes, binds and activates the tyrosine kinase FYN, which in turn blocks epidermal growth factor receptor (EGFR) signaling and leads to keratinocyte growth arrest and differentiation. Associates with the cyclin CCNE1-CDK2-CDKN1B complex and inhibits CDK2 kinase activity, leading to RB1 dephosphorylation and thereby G1 arrest in keratinocytes. In association with RALA activates actin depolymerization, which is necessary for keratinocyte differentiation. In the pre-B cell receptor signaling, functions downstream of BLNK by up-regulating IRF4, which in turn activates L chain gene rearrangement. Regulates epithelial tight junctions (TJs) by phosphorylating occludin (OCLN) on threonine residues, which is necessary for the assembly and maintenance of TJs. In association with PLD2 and via TLR4 signaling, is involved in lipopolysaccharide (LPS)-induced RGS2 down-regulation and foam cell formation. Upon PMA stimulation, mediates glioblastoma cell proliferation by activating the mTOR pathway, the PI3K/AKT pathway and the ERK1-dependent phosphorylation of ELK1. Involved in the protection of glioblastoma cells from irradiation-induced apoptosis by preventing caspase-9 activation. In camptothecin-treated MCF-7 cells, regulates NF-kappa-B upstream signaling by activating IKBKB, and confers protection against DNA damage-induced apoptosis. Promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria. Phosphorylates ATF2 which promotes its nuclear retention and transcriptional activity and negatively regulates its mitochondrial localization.
See full target information PRKCH

Publications (11)

Recent publications for all applications. Explore the full list and refine your search

Molecular medicine reports 32: PubMed40280116

2025

Understanding the role of iron/heme metabolism in the anti‑inflammatory effects of natural sulfur molecules against lipopolysaccharide‑induced inflammation.

Applications

Unspecified application

Species

Unspecified reactive species

Dong Young Kang,Se Won Bae,Kyoung-Jin Jang

eLife 13: PubMed39932433

2025

Mechanical forces pattern endocardial Notch activation via mTORC2-PKC pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yunfei Mu,Shijia Hu,Xiangyang Liu,Xin Tang,Jiayi Lin,Hongjun Shi

MedComm 5:e737 PubMed39309696

2024

Overexpression of PRDM16 attenuates acute kidney injury progression: genetic and pharmacological approaches.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaozhou Li,Fang Xu,Pan Zhang,Liufeng Mao,Yong Guo,Huiling Li,Yuxing Xie,Yijian Li,Yingjun Liao,Junxiang Chen,Donghai Wu,Dongshan Zhang

The Journal of biological chemistry 298:102466 PubMed36087841

2022

Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein kinase C isozymes are involved in mGlu receptor internalization.

Applications

Unspecified application

Species

Unspecified reactive species

Jeffrey R van Senten,Thor C Møller,Ee Von Moo,Sofie D Seiersen,Hans Bräuner-Osborne

International journal of molecular sciences 22: PubMed34884454

2021

Characterization of the Transient Deficiency of PKC Isozyme Levels in Immature Cord Blood T Cells and Its Connection to Anti-Allergic Cytokine Profiles of the Matured Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Khalida Perveen,Alex Quach,Michael J Stark,Susan L Prescott,Simon C Barry,Charles S Hii,Antonio Ferrante

Journal for immunotherapy of cancer 9: PubMed34588224

2021

Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Hsin-Yu Liu,Christophe Pedros,Kok-Fai Kong,Ann J Canonigo-Balancio,Wen Xue,Amnon Altman

Frontiers in pharmacology 11:553852 PubMed33584253

2021

Pharmacological Protein Kinase C Modulators Reveal a Pro-hypertrophic Role for Novel Protein Kinase C Isoforms in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Lotta Pohjolainen,Julia Easton,Reesha Solanki,Heikki Ruskoaho,Virpi Talman

Acta pharmaceutica Sinica. B 11:71-88 PubMed33532181

2021

Activated PKB/GSK-3 synergizes with PKC- signaling in attenuating myocardial ischemia/reperfusion injury potentiation of NRF2 activity: Therapeutic efficacy of dihydrotanshinone-I.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Zeng,Lingling Wang,Jiawei Zhang,Ting Pan,Yinghua Yu,Jingxia Lu,Ping Zhou,Hua Yang,Ping Li

Molecular pharmacology 99:104-113 PubMed33239332

2020

Distinct Regulation of Cardiac Fibroblast Proliferation and Transdifferentiation by Classical and Novel Protein Kinase C Isoforms: Possible Implications for New Antifibrotic Therapies.

Applications

Unspecified application

Species

Unspecified reactive species

S Tuuli Karhu,Heikki Ruskoaho,Virpi Talman

Glia 69:697-714 PubMed33068318

2020

Protein kinase C eta is activated in reactive astrocytes of an Alzheimer's disease mouse model: Evidence for its immunoregulatory function in primary astrocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Amitha Muraleedharan,Noa Rotem-Dai,Itai Strominger,Nikhil Ponnoor Anto,Noah Isakov,Alon Monsonego,Etta Livneh
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com